Lyrica 75 mg (Pregabalin)

Adult dose

This medication is administered orally, divided into two doses daily regardless of meals. 1. Neuropathic pain - Peripheral neuropathic pain: Starting dose of 150 mg daily, may increase to 300 mg daily within 3 to 7 days, and if necessary, may be increased to a maximum of 600 mg at 7-day intervals. - Central neuropathic pain: Starting dose of 150 mg daily, may increase to 300 mg daily after one week.

Child dose

Safety and efficacy data for pediatric patients under 12 years of age and adolescents aged 12 to 17 are insufficient, and usage is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so if mood changes or symptoms of depression occur during use, you should immediately inform your healthcare provider. Do not take if you are allergic to any ingredients in this medication or have genetic conditions such as lactose intolerance. Diabetic patients should be cautious as weight gain may require adjustments in blood sugar control medications. If allergic reactions such as angioedema occur, discontinue the medication immediately. Elderly patients are at risk of falls due to dizziness or drowsiness, so they should be particularly careful during initial usage. Temporary blurred vision or changes in vision may occur, so consult your healthcare provider if symptoms arise. Withdrawal symptoms such as insomnia, headache, and anxiety may appear upon discontinuation, so do not stop taking the medication arbitrarily. Due to the risk of drug abuse, patients with psychiatric histories or a history of drug abuse should consult their healthcare provider before taking this medication. Patients with impaired renal function may require dosage adjustments. Patients with heart disease should be cautious when taking this medication. Caution is advised when taking this medication with opioid analgesics due to an increased risk of central nervous system depression. Patients with respiratory or neurological disorders, or the elderly should follow medical advice as they could experience severe respiratory depression. Pregnant women should avoid this medication in early pregnancy due to the risk of fetal malformations, and women of childbearing potential should use effective contraception. Breastfeeding women should consult their healthcare provider about the possibility of this medication passing into breast milk. Dizziness or drowsiness may occur when driving or operating machinery, so avoid these activities until symptoms are confirmed. Severe skin reactions may rarely occur, so discontinue use and consult your healthcare provider if any skin abnormalities arise. In cases of overdose, confusion, drowsiness, and depression may occur, so immediate medical attention is recommended in emergencies. Keep out of reach of children and do not transfer to other containers.

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in the mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough + fever, yellowing of the skin or eyes, profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, significantly reduced urine output

Mild side effects

• Pharyngitis
• neutropenia
• increased appetite
• decreased appetite
• hypoglycemia
• confusion
• loss of direction
• irritability
• depression
• euphoria

This medication should be stored in a tightly closed container to avoid exposure to air and moisture. It is important to maintain a storage temperature between 15 and 30 degrees Celsius.

Appearance

A hard capsule with a reddish-brown upper part and a white lower part, containing powder that is white or light yellow in color.

Package unit

30 capsules/bottle, 100 capsules/bottle